Literature DB >> 29975626

Bactibilia in women affected with diseases of the biliary tract and pancreas. A STROBE guidelines-adherent cross-sectional study in Southern Italy.

Nicola Serra1, Paola Di Carlo2, Gaspare Gulotta3, Francesco d' Arpa3, Anna Giammanco2, Claudia Colomba2, Giuseppina Melfa3, Teresa Fasciana2, Consolato Sergi4,5.   

Abstract

PURPOSE: Bile is a hepatobiliary lipid-rich sterile solution, and its colonization by microorganisms defines the condition of bactibilia. In this study, we aimed to assess the bile microbiological flora and its potential link with comorbidity in women.
METHODOLOGY: We performed a microbiologic investigation on 53 female patients with biliopancreatic diseases who granted consent, and we analysed the data using a MATLAB platform.
RESULTS: We found that the most frequent disease associated with bactibilia was pancreas head carcinoma (PHC) (P=0.0015), while the least frequent disease was gall bladder carcinoma (GBC) (P=0.0002). The most common microorganisms were Pseudomonas spp. (P<0.0001) and Escherichia coli (P<0.0001). In particular Pseudomonas spp. and E. coli were negatively correlated to PHC presence and positively correlated to CCA by both univariate and multivariate analysis.
CONCLUSIONS: Gram-negative bacteria have been linked to a tumour-associated inflammatory status. In the last 30 years, the analysis of mortality rate in Italy for PHC and GBC shows an increasing and a decreasing trend, respectively. Although this study targeted only 53 patients and does not reflect the frequency of diagnosis in a Southern Italian population, the decrease in GBC may raise the suggestion ofnon-adherence to a Mediterranean diet that may have become more prevalent in Southern Italy since the 1990s.

Entities:  

Keywords:  bile; biliary disease; microorganisms; pancreatic disease

Mesh:

Year:  2018        PMID: 29975626     DOI: 10.1099/jmm.0.000787

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  12 in total

Review 1.  Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome.

Authors:  Ziying Zhang; Haosheng Tang; Peng Chen; Hui Xie; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2019-10-12

Review 2.  Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapy.

Authors:  Roseanna C Wheatley; Elaine Kilgour; Timothy Jacobs; Angela Lamarca; Richard A Hubner; Juan W Valle; Mairéad G McNamara
Journal:  Br J Cancer       Date:  2021-10-18       Impact factor: 9.075

3.  Infective Endocarditis: Preliminary Results of a Cohort Study in the Southern Italian Population.

Authors:  Nicola Serra; Claudia Colomba; Paola Di Carlo; Gabriele Palermo; Teresa Fasciana; Anna Giammanco; Giuseppina Novo; Teresa Rea; Maria Michela Marino; Vincenzo Argano; Consolato Sergi
Journal:  Cureus       Date:  2020-05-28

Review 4.  The microbiota and microbiome in pancreatic cancer: more influential than expected.

Authors:  Miao-Yan Wei; Si Shi; Chen Liang; Qing-Cai Meng; Jie Hua; Yi-Yin Zhang; Jiang Liu; Bo Zhang; Jin Xu; Xian-Jun Yu
Journal:  Mol Cancer       Date:  2019-05-20       Impact factor: 27.401

Review 5.  Non-celiac wheat sensitivity: rationality and irrationality of a gluten-free diet in individuals affected with non-celiac disease: a review.

Authors:  Consolato Sergi; Vincenzo Villanacci; Antonio Carroccio
Journal:  BMC Gastroenterol       Date:  2021-01-06       Impact factor: 3.067

Review 6.  A Comprehensive Review of the Current and Future Role of the Microbiome in Pancreatic Ductal Adenocarcinoma.

Authors:  Nabeel Merali; Tarak Chouari; Kayani Kayani; Charles J Rayner; José I Jiménez; Jonathan Krell; Elisa Giovannetti; Izhar Bagwan; Kate Relph; Timothy A Rockall; Tony Dhillon; Hardev Pandha; Nicola E Annels; Adam E Frampton
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

7.  Role of biliary stent and neoadjuvant chemotherapy in the pancreatic tumor microbiome.

Authors:  Harika Nalluri; Eric Jensen; Christopher Staley
Journal:  BMC Microbiol       Date:  2021-10-16       Impact factor: 3.605

Review 8.  Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances.

Authors:  Hao Qin; Baowen Yuan; Wei Huang; Yan Wang
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

9.  A systematic review on omics data (metagenomics, metatranscriptomics, and metabolomics) in the role of microbiome in gallbladder disease.

Authors:  Paola Di Carlo; Nicola Serra; Rosa Alduina; Riccardo Guarino; Antonio Craxì; Anna Giammanco; Teresa Fasciana; Antonio Cascio; Consolato M Sergi
Journal:  Front Physiol       Date:  2022-08-30       Impact factor: 4.755

10.  Novel Discoveries Targeting Pathogenic Gut Microbes and New Therapies in Pancreatic Cancer: Does Pathogenic E. coli Infection Cause Pancreatic Cancer Progression Modulated by TUBB/Rho/ROCK Signaling Pathway? A Bioinformatic Analysis.

Authors:  Wenhao Luo; Zhe Cao; Jiangdong Qiu; Yueze Liu; Lianfang Zheng; Taiping Zhang
Journal:  Biomed Res Int       Date:  2020-05-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.